The Impact of Telehealth for Opioid Use Disorder Treatment Retention During the COVID-19 Pandemic
The COVID-19 pandemic fundamentally changed the healthcare landscape, presenting both challenges and opportunities. One of the more concerning trends during this period was the...
The Gold Standard in Opioid Use Disorder Treatment: Addressing Access Challenges and the Growing Concern of Buprenorphine Diversion
Medication-based treatment has long been recognized as the gold standard for treating opioid use disorder (OUD). Medications like buprenorphine are widely regarded for their...
Navigating the Landscape of Substance Use Disorder Treatment in 2024: Challenges, Breakthroughs, and Hope for the Future
The year 2024 in the substance use disorder (SUD) treatment industry has been a dynamic mix of formidable challenges, technological disruptions, and unexpected breakthroughs....
Headway Leads the Charge in National Behavioral Health Network Expansion
Headway, a digital behavioral health company, has announced a significant milestone with its national behavioral health network expansion. This expansion comes through strategic partnerships...
PursueCare Secures $20 Million Series B Funding, Acquires Pear Therapeutics’ Groundbreaking Digital Tools to Expand Virtual Substance Use Disorder Treatment
PursueCare, a leader in virtual substance use disorder (SUD) treatment, is making major strides in reshaping how addiction care is delivered. The Middletown, Connecticut-based...
Expanding Access to Mental Health and SUD Treatment in Rural Communities: The Home-Based Telemental Health Care Act
Access to healthcare in rural communities has long been a challenge. For many individuals in these areas, obtaining specialized care for mental health issues...
